10.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$10.72
Aprire:
$10.65
Volume 24 ore:
3.45M
Relative Volume:
0.69
Capitalizzazione di mercato:
$2.09B
Reddito:
$3.68B
Utile/perdita netta:
$-627.00M
Rapporto P/E:
-3.3358
EPS:
-3.1477
Flusso di cassa netto:
$104.00M
1 W Prestazione:
-8.14%
1M Prestazione:
-9.95%
6M Prestazione:
-17.19%
1 anno Prestazione:
-23.36%
Dentsply Sirona Inc Stock (XRAY) Company Profile
Nome
Dentsply Sirona Inc
Settore
Industria
Telefono
844-546-3722
Indirizzo
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
XRAY
Dentsply Sirona Inc
|
10.50 | 2.14B | 3.68B | -627.00M | 104.00M | -3.1477 |
|
ISRG
Intuitive Surgical Inc
|
360.46 | 124.79B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
176.42 | 48.98B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
66.55 | 33.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
219.58 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
32.39 | 29.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Sell |
| 2026-02-19 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-11-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Downgrade | Needham | Buy → Hold |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-23 | Downgrade | Jefferies | Buy → Hold |
| 2025-01-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Reiterato | Needham | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-11-16 | Iniziato | Needham | Buy |
| 2023-11-10 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Aggiornamento | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-01 | Ripresa | Credit Suisse | Outperform |
| 2021-08-09 | Reiterato | H.C. Wainwright | Neutral |
| 2021-08-06 | Reiterato | Barrington Research | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-02 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Reiterato | H.C. Wainwright | Neutral |
| 2021-01-05 | Reiterato | H.C. Wainwright | Neutral |
| 2020-12-18 | Downgrade | Stifel | Buy → Hold |
| 2020-11-17 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Reiterato | H.C. Wainwright | Neutral |
| 2020-10-22 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Neutral |
| 2020-06-16 | Iniziato | Piper Sandler | Overweight |
| 2020-06-15 | Reiterato | H.C. Wainwright | Neutral |
| 2020-05-27 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Reiterato | H.C. Wainwright | Neutral |
| 2020-04-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Downgrade | Goldman | Buy → Neutral |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-19 | Reiterato | Stifel | Buy |
| 2019-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Aggiornamento | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Iniziato | Evercore ISI | In-line |
| 2019-07-09 | Reiterato | H.C. Wainwright | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Dentsply Sirona Inc Borsa (XRAY) Ultime notizie
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 182,661 Shares of DENTSPLY SIRONA Inc. $XRAY - marketbeat.com
Dentsply Investor Suit Over Pandemic Woes Lined Up For Trial - Law360
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure - finance.yahoo.com
Law firm investigates Dentsply Sirona officers for possible breaches of shareholder duties - Pluang
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? - The Conway Daily Sun
Legal & General Group Plc Makes New $3.25 Million Investment in DENTSPLY SIRONA Inc. $XRAY - marketbeat.com
DENTSPLY SIRONA (XRAY) Returns To Profit As Investors Weigh Its Valuation - finance.yahoo.com
Dentsply Sirona (XRAY) Stock May Still Trade At A Discount - finance.yahoo.com
The Manufacturers Life Insurance Company Takes Position in DENTSPLY SIRONA Inc. $XRAY - marketbeat.com
Does XRAY’s Profit Recovery and Reaffirmed 2026 Outlook Shift the Dentsply Sirona Thesis? - finance.yahoo.com
A live webcast will carry Dentsply Sirona’s Sept. 15 presentation - Stock Titan
Dentsply Sirona (XRAY) Swings Back To Profit While Sales Keep Sliding - finance.yahoo.com
Is It Too Late to Buy Dentsply Sirona Inc (XRAY) After 4.8% Rall - GuruFocus
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of "Hold" from Analysts - marketbeat.com
Bank of New York Mellon Corp Makes New Investment in DENTSPLY SIRONA Inc. $XRAY - marketbeat.com
DENTSPLY SIRONA Inc (DY2) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Private Management Group Inc. - marketbeat.com
Algert Global LLC Acquires New Position in DENTSPLY SIRONA Inc. $XRAY - marketbeat.com
Zacks Research Forecasts Weaker Earnings for DENTSPLY SIRONA - MarketBeat
Dentsply Sirona Inc (XRAY) Key Financial Ratios – Valuation, Profitability & More - Value Research
Deutsche Bank AG Makes New Investment in DENTSPLY SIRONA Inc. $XRAY - marketbeat.com
26,711,079 Shares in DENTSPLY SIRONA Inc. $XRAY Acquired by BlackRock Inc. - marketbeat.com
Ieq Capital LLC Invests $1.87 Million in DENTSPLY SIRONA Inc. $XRAY - marketbeat.com
Paradigm Capital Management Inc. NY Makes New $39.77 Million Investment in DENTSPLY SIRONA Inc. $XRAY - marketbeat.com
XRAY 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages DENTSPLY SIRONA Inc. (XRAY) Investors with Over $1 Million Losses to Contact Firm's Attorneys, Securities Class Action Pending - TMX Newsfile
1,167,350 Shares in DENTSPLY SIRONA Inc. $XRAY Acquired by Heartland Advisors Inc. - marketbeat.com
Edmond DE Rothschild Holding S.A. Purchases Shares of 4,503,300 DENTSPLY SIRONA Inc. $XRAY - MarketBeat
More than 13 million Americans face incontinence challenges; Wellspect launches a home system - Stock Titan
DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Bank of America Corp DE - MarketBeat
Royal Bank of Canada Raises Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript - AOL.com
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call - Yahoo Finance
DENTSPLY Sirona Inc (XRAY) News, Articles, Events & Latest Updates - Stocktwits
Dentsply Sirona (XRAY): Southpoint reports 7M-share, 3.5% ownership in 13G/A - Stock Titan
Is DENTSPLY SIRONA’s (XRAY) Steady Buyback and Reaffirmed Outlook Reframing Its Risk‑Reward Profile? - simplywall.st
DENTSPLY SIRONA (XRAY) gains AQR Capital as 5.22% beneficial owner - Stock Titan
DS World Las Vegas 2026 connects clinical and laboratory education - Dental Tribune US
DENTSPLY SIRONA (XRAY) CFO awarded 104,200 stock options and 24,014 RSUs - Stock Titan
Pacer Advisors Inc. Has $266,000 Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (XRAY) SVP Frohning reports 802 tax-withheld shares - Stock Titan
XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds - Yahoo Finance
DENTSPLY SIRONA (XRAY): Navigating Challenges With A 17.66% Potential Upside - DirectorsTalk Interviews
Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today - Yahoo Finance
Dentsply Sirona Earnings: Weak Recovery Momentum Unchanged as Soft Volume Weighs on Results - Morningstar
Empowered Funds LLC Grows Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona (XRAY) Stock Drops As Revenue Weakens Despite Profit Rebound - Sahm
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Form 8K Dentsply Sirona Inc For: 7 August By Investing.com - Investing.com Nigeria
DENTSPLY SIRONA Q2 Earnings Call Highlights - MarketBeat
1% Undervalued? DENTSPLY SIRONA (XRAY) As Earnings Test Its Recovery Story - Yahoo Finance
Dentsply Sirona Reports $898 Million in Net Sales for Second Quarter 2026 - Orthodontic Products
Dentsply Sirona Inc Azioni (XRAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):